Research

In the United States and The Netherlands

Chung-Jansen Syndrome is named after the two doctors/researchers who have been conducting separate research into this gene variance.

The Netherlands

Dr. Sandra Jansen, together with Dr. Bert de Vries, published one of the first articles about abnormalities in the PHIP gene in 2017: nature.com.
In 2021 she teamed up with Dr. Agnies van Eeghen to start a PHIP expertise outpatient clinic at Amsterdam UMC. Adult patients or parents of children with the syndrome are welcome here for an intake interview. The purpose of the outpatient clinic is to set up a regional care network and to inform patients, their parents or caregivers and other health professionals.

Episign Research

Recently, a research group from Amsterdam UMC (including Niels Vos and Mieke van Haelst) together with colleagues from other countries published a new article on, among other things, Chung-Jansen syndrome. It was investigated whether people with Chung-Jansen syndrome have the same ‘signature’ when looking at something called ‘epigenetics’. There indeed appears to be a specific ‘epigenetic signature’ for people with Chung-Jansen syndrome. This will make it easier to diagnose other patients in the future and provide more clarity about the diagnosis if there is uncertainty.

Read the article.

United States

Natural History Study
The ongoing research of the Natural History Study collects data from people with Chung Jansen syndrome to gain valuable insights into how the disease presents and develops over time. Examining the condition at different ages over time provides important information about the evolution of Chung Jansen syndrome throughout life. The information gathered allows researchers and clinicians to work on improving guidelines and support for medical management, and to inform future clinical trials.

For more information and/or participation in this study, please send an email via the email addresses listed on the contact page.

Dr’s involved in the Study:
Dr. Wendy Chung